Traditional mineral extraction methods often involve high chemical and water usage, posing environmental risks and limiting the economic viability of low-grade mineral deposits. Existing processes may also lack selectivity, leading to inefficient recovery of target metals.

Giraffe Bio develops biomolecular technology that integrates into existing mineral extraction processes to enhance metal recovery and selectivity while minimizing chemical and water usage. The company utilizes proprietary biochips for high-throughput testing of biomolecules, identifying candidates that optimize metal extraction under specific mining conditions. Cell-free systems directly synthesize proteins on these biochips, creating a data library used to refine biomolecule designs. AI-driven data analysis further optimizes biomolecules for specific mining conditions, maximizing extraction efficiency and selectivity.

Proprietary biochips created using lithography and microfluidics for high-throughput biomolecule testing.

Cell-free systems for direct protein synthesis on biochips, enabling efficient interaction testing with mining samples.

AI-driven data analysis to refine biomolecule designs, optimizing them for specific mining conditions.

Scalable platform applicable to multiple metals and industries.

Customizable solutions tailored for specific geological needs.

Technology unlocks value from low-grade deposits.

Reduces water and chemical use in mineral extraction.

Giraffe Bio's primary customers are mining companies seeking to increase yields, reduce costs, and improve the sustainability of their mineral extraction processes.

Giraffe Bio follows a B2B model, partnering with mining companies to increase yields and reduce costs.